Literature DB >> 9344869

The inhibition of synthesis of a beta-chemokine, monocyte chemotactic protein-1 (MCP-1) by progesterone.

R W Kelly1, G G Carr, S C Riley.   

Abstract

The control of chemokines in reproductive tissues has not been well characterised. Progesterone plays a major part in many reproductive processes and an interaction between progesterone and the immune system has been postulated. MCP-1 is a beta chemokine that attracts and activates macrophages, controls vascular smooth muscle cells, and can modulate T helper cell cytokine production. MCP-1 may also play a role in reproductive processes such as ovulation and parturition. MCP-1 synthesis is stimulated by the transcription factor NF-kappa B and is inhibited by glucocorticoid but the relevance of progesterone control in reproductive tissue is unknown. The effects of progesterone on the production in both choriodecidual cells and a breast cancer cell line T47D, which expresses an oestrogen insensitive progesterone receptor, were investigated. A synthetic progestin (medroxyprogesterone acetate) inhibits choriodecidual cell production of MCP-1; this inhibition was reversed by the antiprogestin RU486. MCP-1 release from T47D cells can be stimulated by IL-1 and this production is inhibited by progesterone with an ED50 of less than 10(-9) M. A glucocorticoid (dexamethasone) had no effect on MCP-1 release in this system, suggesting that glucocorticoid receptor-mediated responses were impaired under these conditions. These results demonstrate that an indirect effect of progesterone on the immune system is possible in reproductive tissues, whereby the initial effect of progesterone on epithelial or fibroblast cells would be transmitted to leukocytes. Copyright 1997 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9344869     DOI: 10.1006/bbrc.1997.7502

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

Review 1.  Molecular Regulation of Parturition: A Myometrial Perspective.

Authors:  Nora E Renthal; Koriand'r C Williams; Alina P Montalbano; Chien-Cheng Chen; Lu Gao; Carole R Mendelson
Journal:  Cold Spring Harb Perspect Med       Date:  2015-09-03       Impact factor: 6.915

2.  Regulation of monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha and interleukin-1beta in first trimester human decidual cells: implications for preeclampsia.

Authors:  Charles J Lockwood; Paul Matta; Graciela Krikun; Louise A Koopman; Rachel Masch; Paolo Toti; Felice Arcuri; Se-Te Joseph Huang; Edmund F Funai; Frederick Schatz
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

Review 3.  Progesterone exerts neuroprotective effects after brain injury.

Authors:  Donald G Stein
Journal:  Brain Res Rev       Date:  2007-07-27

Review 4.  Chemokines: novel targets for breast cancer metastasis.

Authors:  Simi Ali; Gwendal Lazennec
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

5.  Activation and repression of interleukin-12 p40 transcription by erythroid Kruppel-like factor in macrophages.

Authors:  Qi Luo; Xiaojing Ma; Sharon M Wahl; James J Bieker; Merlin Crossley; Luis J Montaner
Journal:  J Biol Chem       Date:  2004-02-19       Impact factor: 5.157

Review 6.  Minireview: fetal-maternal hormonal signaling in pregnancy and labor.

Authors:  Carole R Mendelson
Journal:  Mol Endocrinol       Date:  2009-03-12

7.  St. John's Wort protein, p27SJ, regulates the MCP-1 promoter.

Authors:  Ruma Mukerjee; Satish L Deshmane; Nune Darbinian; Marta Czernik; Kamel Khalili; Shohreh Amini; Bassel E Sawaya
Journal:  Mol Immunol       Date:  2008-07-22       Impact factor: 4.407

Review 8.  Immune aspects and myometrial actions of progesterone and CRH in labor.

Authors:  Nikolaos Vrachnis; Fotodotis M Malamas; Stavros Sifakis; Panayiotis Tsikouras; Zoe Iliodromiti
Journal:  Clin Dev Immunol       Date:  2011-10-19

9.  Inflammatory mediators in breast cancer: coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition.

Authors:  Gali Soria; Maya Ofri-Shahak; Ilana Haas; Neora Yaal-Hahoshen; Leonor Leider-Trejo; Tal Leibovich-Rivkin; Polina Weitzenfeld; Tsipi Meshel; Esther Shabtai; Mordechai Gutman; Adit Ben-Baruch
Journal:  BMC Cancer       Date:  2011-04-12       Impact factor: 4.430

10.  Oestrogen receptor negative breast cancers exhibit high cytokine content.

Authors:  Carine Chavey; Frédéric Bibeau; Sophie Gourgou-Bourgade; Sandrine Burlinchon; Florence Boissière; Daniel Laune; Sylvie Roques; Gwendal Lazennec
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.